{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:05:33Z","timestamp":1788930333037,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T00:00:00Z","timestamp":1706832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jmii.2024.01.009","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T19:22:32Z","timestamp":1707247352000},"page":"300-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Comparison of in\u00a0vitro synergy between polymyxin B or colistin in combination with 16 antimicrobial agents against multidrug-resistant Acinetobacter baumannii isolates"],"prefix":"10.1016","volume":"57","author":[{"given":"Yuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luying","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0025-0010","authenticated-orcid":false,"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixia","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4845-5904","authenticated-orcid":false,"given":"Yonghong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2024.01.009_bib1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.tim.2012.12.002","article-title":"Emerging therapies for multidrug resistant Acinetobacter baumannii","volume":"21","author":"Garc\u00eda-Quintanilla","year":"2013","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.jmii.2024.01.009_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijantimicag.2012.09.008","article-title":"Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages","volume":"41","author":"Zarrilli","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2024.01.009_bib3","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/cid\/cis552","article-title":"Costs of healthcare-and community-associated infections with antimicrobial-resistant versus antimicrobial-susceptible organisms","volume":"55","author":"Neidell","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2024.01.009_bib4","doi-asserted-by":"crossref","first-page":"e00310","DOI":"10.1128\/mSphere.00310-16","article-title":"Global assessment of the activity of tigecycline against multidrug-resistant gram-negative pathogens between 2004 and 2014 as part of the tigecycline evaluation and surveillance trial","volume":"2","author":"Giammanco","year":"2017","journal-title":"mSphere"},{"key":"10.1016\/j.jmii.2024.01.009_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/1120009X.2017.1338377","article-title":"Epidemiology of multidrug-resistant Acinetobacter baumannii strains in Iran: a systematic review and meta-analysis","volume":"29","author":"Bialvaei","year":"2017","journal-title":"J Chemother"},{"key":"10.1016\/j.jmii.2024.01.009_bib6","first-page":"276","article-title":"Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America","volume":"42","author":"Labarca","year":"2016","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.jmii.2024.01.009_bib7","doi-asserted-by":"crossref","first-page":"1217270","DOI":"10.3389\/fmicb.2023.1217270","article-title":"Metabolomics revealed mechanism for the synergistic effect of sulbactam, polymyxin-B and amikacin combination against Acinetobacter baumannii","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jmii.2024.01.009_bib8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4103\/2319-4170.132879","article-title":"Influencing factors of successful eradication of multidrug-resistant Acinetobacter baumannii in the respiratory tract with aerosolized colistin","volume":"37","author":"Chen","year":"2014","journal-title":"Biomed J"},{"key":"10.1016\/j.jmii.2024.01.009_bib9","doi-asserted-by":"crossref","first-page":"1229473","DOI":"10.3389\/fcimb.2023.1229473","article-title":"Retained colistin susceptibility in clinical Acinetobacter baumannii isolates with multiple mutations in pmrCAB and lpxACD operons","volume":"13","author":"Zafer","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jmii.2024.01.009_bib10","first-page":"107035","article-title":"Battle of polymyxin induced nephrotoxicity: polymyxin B versus colistin","author":"Ball\u0131","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2024.01.009_bib11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ijantimicag.2018.10.020","article-title":"Safety and efficacy of colistin alone or in combination in adults with Acinetobacter baumannii infection: a systematic review and meta-analysis","volume":"53","author":"Wang","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2024.01.009_bib12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijantimicag.2017.03.030","article-title":"Reinforcement of an antimicrobial stewardship task force aims at a better use of antibiotics of last resort: the COLITIFOS study","volume":"50","author":"Davido","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2024.01.009_bib13","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1089\/mdr.2018.0283","article-title":"Pharmacodynamic effects of sulbactam\/meropenem\/polymyxin-B combination against extremely drug resistant Acinetobacter baumannii using checkerboard information","volume":"25","author":"Menegucci","year":"2019","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jmii.2024.01.009_bib14","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/AAC.00999-09","volume":"54","author":"Meletiadis","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2024.01.009_bib15","first-page":"1214","article-title":"Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae in time-lapse microscopy and time-kill experiments","volume":"26","author":"Wistrand-Yuen","year":"2020","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2024.01.009_bib16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/CMR.00058-14","article-title":"Antimicrobial heteroresistance: an emerging field in need of clarity","volume":"28","author":"El-Halfawy","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jmii.2024.01.009_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fcimb.2017.00055","article-title":"Biology of acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options","volume":"7","author":"Lee","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jmii.2024.01.009_bib18","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/cid\/cit367","article-title":"Polymyxins: wisdom does not always come with age","volume":"57","author":"Kassamali","year":"2013","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.jmii.2024.01.009_bib19","doi-asserted-by":"crossref","first-page":"1209063","DOI":"10.3389\/fphar.2023.1209063","volume":"14","author":"Wu","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jmii.2024.01.009_bib20","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/jac\/dkm357","article-title":"Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review","volume":"60","author":"Zavascki","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2024.01.009_bib21","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/jac\/dks084","article-title":"Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies","volume":"67","author":"Cai","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2024.01.009_bib22","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1128\/AAC.02435-13","article-title":"Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections","volume":"58","author":"Sirijatuphat","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2024.01.009_bib23","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1128\/AAC.01230-13","article-title":"Systematic review and meta-analysis of in\u00a0vitro synergy of polymyxins and carbapenems","volume":"57","author":"Zusman","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2024.01.009_bib24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijantimicag.2005.10.012","article-title":"In\u00a0vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units","volume":"27","author":"Timurkaynak","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2024.01.009_bib25","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/s41564-020-0737-6","article-title":"A nutrient-limited screen unmasks rifabutin hyperactivity for extensively drug-resistant Acinetobacter baumannii","volume":"5","author":"Luna","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jmii.2024.01.009_bib26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/cid\/cit253","article-title":"Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial","volume":"57","author":"Durante-Mangoni","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2024.01.009_bib27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/cid\/ciu213","article-title":"Colistin and polymyxin B: peas in a pod, or chalk and cheese?","volume":"59","author":"Nation","year":"2014","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.jmii.2024.01.009_bib28","first-page":"315","article-title":"Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004)","volume":"12","author":"Gales","year":"2006","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2024.01.009_bib29","first-page":"471","article-title":"Time-kill and post-antibiotic effect of colistin at different static concentrations in in\u00a0vitro Acinetobacter baumannii","volume":"37","author":"Rasidin","year":"2020","journal-title":"Trop Biomed"},{"key":"10.1016\/j.jmii.2024.01.009_bib30","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jinf.2008.11.002","article-title":"Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme","volume":"58","author":"Yau","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.jmii.2024.01.009_bib31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/jac\/dkl512","article-title":"In\u00a0vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates","volume":"59","author":"Owen","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2024.01.009_bib32","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1128\/AAC.00103-06","article-title":"Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii","volume":"50","author":"Li","year":"2006","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118224000367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118224000367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T10:44:23Z","timestamp":1711104263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118224000367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1684118224000367"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2024.01.009","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of in\u00a0vitro synergy between polymyxin B or colistin in combination with 16 antimicrobial agents against multidrug-resistant Acinetobacter baumannii isolates","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2024.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}